HealthDay News — COVID-19 is associated with long-term risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Nov. 6 in JAMA Dermatology.

Pembrolizumab, an immunotherapy medication, significantly enhanced disease-free survival when added to the standard of care ...

Medical Dialogues presents a rare disease series, delving into the realm of uncommon medical conditions. Rare diseases are ...

Abbisko announces positive results from phase 3 MANEUVER study of pimicotinib to treat tenosynovial giant cell tumour: Shanghai Wednesday, November 13, 2024, 18:00 Hrs [IST] Abbis ...

Received tentative approval from the FDA for YUTREPIATM (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) ...

To create a cervix-on-a-chip, the researchers added cells that line the cervical canal to one channel of a microfluidic ...

Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors highli ...

As someone with two cats, a messy eight-year-old child, and a personal aversion to crumbs, debris and mess, the canister ...

Collagen protein: Derived from animal bones and connective tissues ... needle-like crystals in a joint or surrounding tissue, causing pain, inflammation, and swelling. As per a study published in ...